Patent classifications
A61F6/16
INFLATABLE INTRAUTERINE BALLOON
Disclosed herein are inflatable balloon apparatuses for use in stopping massive blood flow from a uterine wall due trauma or disease. Also disclosed is a method for using the apparatuses.
Anatomical support systems, devices, and related methods
The systems, devices and methods provide customizable and adjustable support to anatomical tissue or organs, such as pelvic, vaginal, uterine, cervical, bladder, rectal, among others, or any combination thereof. The anatomical support device may include a support member having a periphery that surrounds an opening. The support member may be configured to releasably and adjustably expand between one or more expanding states from a resting state and contract to the resting state. The support member may include a first portion and a second portion disposed along the periphery. Each portion may include a passage cross-sectional area and a wall thickness. The first wall thickness and/or the first passage cross-sectional area of the first portion may be different from the second wall thickness and/or the second passage cross-sectional area of the second portion.
Pessary for transvaginal haemostasis
Disclosed is a pessary for transvaginal haemostasis, wherein the radial dimension of a balloon body can be changed to form a relatively large pressure on a vaginal wall, therefore achieving the effect of high-pressure haemostasis. The pessary for transvaginal haemostasis comprises: the balloon body, being made of an expandable material, the balloon body having a cavity, the cavity having a filling hole so that a fluid can be filled into or drawn out of the cavity through the filling hole, the balloon body having a first end and a second end, the balloon body having at least one hollow passage, the passage running through the first end and the second end of the balloon body and not being in communication with the cavity, an outer surface of the balloon body having at least one channel, and the channel also running through the first end and the second end of the balloon body; and a support body having a coupling end and a support end, the coupling end being coupled to the second end of the balloon body, the support body having a through hole in communication with the passage, and the peripheral surface of the support body having at least one recessed portion corresponding to the channel.
Treating gynecological malignancies with deployable implants
A method of treating a gynecological malignancy includes introducing an implant within a uterus of a patient and positioning the implant adjacent to an endometrium of the uterus to enable a bioactive agent supported on the implant to treat the gynecological malignancy. The implant may be one or more deployable implants including a balloon, an IUD, a stent, or combinations thereof. Such implants may be introduced by one or more surgical instruments.
Treating gynecological malignancies with deployable implants
A method of treating a gynecological malignancy includes introducing an implant within a uterus of a patient and positioning the implant adjacent to an endometrium of the uterus to enable a bioactive agent supported on the implant to treat the gynecological malignancy. The implant may be one or more deployable implants including a balloon, an IUD, a stent, or combinations thereof. Such implants may be introduced by one or more surgical instruments.
TREATING GYNECOLOGICAL MALIGNANCIES WITH DEPLOYABLE IMPLANTS
A method of treating a gynecological malignancy includes introducing an implant within a uterus of a patient and positioning the implant adjacent to an endometrium of the uterus to enable a bioactive agent supported on the implant to treat the gynecological malignancy. The implant may be one or more deployable implants including a balloon, an IUD, a stent, or combinations thereof. Such implants may be introduced by one or more surgical instruments.
TREATING GYNECOLOGICAL MALIGNANCIES WITH DEPLOYABLE IMPLANTS
A method of treating a gynecological malignancy includes introducing an implant within a uterus of a patient and positioning the implant adjacent to an endometrium of the uterus to enable a bioactive agent supported on the implant to treat the gynecological malignancy. The implant may be one or more deployable implants including a balloon, an IUD, a stent, or combinations thereof. Such implants may be introduced by one or more surgical instruments.
Systems and methods for endometrial ablation
An endocervical seal has a sleeve with a passageway for receiving an intrauterine interventional or diagnostic tool. The sleeve has a coaxially disposed outer balloon with a distal portion configured to inflate in a cervical os and a proximal portion configured to inflate in a cervical canal.
Systems and methods for endometrial ablation
An endocervical seal has a sleeve with a passageway for receiving an intrauterine interventional or diagnostic tool. The sleeve has a coaxially disposed outer balloon with a distal portion configured to inflate in a cervical os and a proximal portion configured to inflate in a cervical canal.
DEVICE AND METHOD FOR PROTECTING A FETUS FROM INJURY DURING UMBILICAL CORD PROLAPSE
A method of protecting a fetus from injury during umbilical cord prolapse includes delivering a device which includes a hollow sheath and a compliant portion partially or completely surrounding the hollow sheath into a vaginal canal of a patient. The device is maneuvered within the vaginal canal and/or cervical opening such that a prolapsed umbilical cord enters the hollow sheath. The device is then positioned within a uterus of the patient, such that a first face of the compliant portion contacts a fetus and a second face of the compliant portion contacts a wall of the uterus.